Shailja Dixit, MD, MS, MPH is a renowned Physician Executive and the Chief Executive Officer of Curio Digital Therapeutics, a groundbreaking healthcare company specializing in women's behavioral and physical health.
With a diverse educational background, Shailja holds a Master's degree in informatics and a Master's degree in public health from Columbia University, NY, showcasing her commitment to advancing healthcare through the integration of technology and data-driven solutions.
With over two decades of experience in the healthcare and life sciences industry, Shailja has achieved remarkable success in various executive leadership positions at prominent companies such as Sanofi, Allergan, and GE. Her expertise in launching innovative medicines has earned her accolades and recognition, including being voted as the Innovator of the Year at GE in 2008.
Shailja's visionary mindset and contributions to the field of "Big Data" in Life Sciences led to her nomination as a Top 50 Thought Leader in the area in 2016. Her valuable insights and expertise were also showcased in the Pharma Executive Magazine cover-page article titled "Real-World Evidence: From Volume to Value" in October 2016.
Throughout her career, Shailja has played a pivotal role in building and leading successful companies, with multiple successful exits to her credit. However, her most significant accomplishment came three and a half years ago when she founded Curio Digital Therapeutics. Shailja's driving passion to provide appropriate and timely support for women dealing with emotional, behavioral, and physical health conditions across their lifecycle led to the creation of Curio—a digital-first platform exclusively dedicated to women's behavioral and physical health.
Curio is the only company to be classified as “software as a medical device” bringing an innovative approach that combines self-guided evidence-based interventions with access to experienced coaches and therapists. This unique combination empowers women to take control of their physical and behavioral well-being and provides them with the tools they need to lead healthier and more fulfilling lives.
Under Shailja's leadership, Curio Digital Therapeutics has gained industry-wide recognition and numerous awards, including being named the most innovative company by BioNJ and one of the "companies to watch" by Business Insider. In addition, the company was awarded the prestigious "Venture of the Year" title in 2022.
Shailja’s exceptional leadership and entrepreneurial achievements have not gone unnoticed, as she has been acknowledged as a finalist for the prestigious E&Y Entrepreneur of the Year award.
Through her relentless dedication to improving women's behavioral and physical health and her visionary approach to digital therapeutics, Shailja continues to leave an indelible mark on the healthcare industry, making a positive impact on the lives of countless women seeking support and empowerment. Her unwavering commitment to creating innovative and accessible solutions for women's physical and mental well-being, positions her as a true trailblazer and a respected figure in the healthcare community.
Friday 13th october
Impacting Women's Health Through Femtech Innovation
Fire Side Chat: From Idea to Triumph: Crafting a FemTech Success Story
Shailja Dixit, CEO and Founder, Curio Digital Therapeutics
In Conversation with
Reenita Das, Partner, Senior Vice President, Healthcare & Life Sciences, Frost & Sullivan